Medicine

Health experts say the Pfizer and Moderna COVID-19 vaccines are safe following rare incidents of heart inflammation, and that the benefits of vaccination outweigh the risks.

WHYY’s Health Desk Help Desk answers more questions about the COVID-19 vaccine from people with very specific concerns about its effect and effectiveness.

Why are we falling short of President Biden's 70% vaccination rate target for July 4th? Also, the latest on the Delta variant and how barber shops are becoming vaccine hubs.

A third shop just opened in Center City, while some neighborhoods don’t have any.

An on-again/off-again/on-again exemption means no special training is required for medical professionals to prescribe buprenorphine to up to 30 patients each.

Long COVID effects are still unexplainable, and a cure is elusive. Some hope the vaccine will help. But doctors say that depends on the symptoms.

Former Philadelphia Mayor Michael Nutter on his prostate cancer, restrictive voting bills in Pa., and the plight of endangered red knots migrating through Delaware Bay.

According to Novavax, the vaccine's manufacturer, it had a 100% efficacy against the original strain of the coronavirus, and 93% efficacy against more worrisome variants.

What is the risk, if any, while someone is expecting? WHYY’s Health Desk Help Desk looked into what the research is showing.

It can be genuinely thrilling when a new drug is approved for use in the U.S. It may be a big step forward in treating folks with, say, HIV or diabetes or breast cancer.

The agency approved an Alzheimer's drug called Aduhelm against the wishes of nearly every member on the panel.

U.S. regulators are allowing the release of 10 million doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory, but many other doses can't be used.

FDA approved the controversial Alzheimer’s drug aducanumab. We'll talk with Penn Memory Center's Dr. Jason Karlawish about the decision and the state of Alzheimer's research.

The Food and Drug Administration said it granted approval to the drug developed by Biogen for patients with Alzheimer's disease.

Instead of putting genetic instructions into people whose cells then make a viral protein, the vaccines from Novavax, Medicago and Sanofi carry a spike protein payload.